ライフサイエンスコーパス: SAPS

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します

1 SAPS ensures that a significant gene set is not only abl

2 SAPS is a powerful new method for deriving robust progno

3 SAPS-II score was the sole predictor of failure.

4 We report here finding a SAPS sequence domain encoded in only a single gene each

5 ed at least one dose of study drug and had a SAPS assessment at baseline and at least one follow-up.

6 osed of the PP6 catalytic subunit bound to a SAPS domain scaffold subunit that associates with Ankrd2

7 atio, 1.93; 95% CI, 1.26-2.94; P = .002) and SAPS II, whereas immunosuppression and myocarditis as th

8 ng standard measures achieve significance by SAPS.

9 An easy-to-calculate score combining SAPS II and serum albumin level is a good prediction of

10 Tagged PP6 coprecipitated endogenous SAPS domain subunits and Ankrd28.

11 3 ( >.14) for MPM II0, and 8.17 (p >.42) for SAPS II, after customization.

12 tic curve was 0.83 for MPM II0 and 0.872 for SAPS II following model customization.

13 value for SOFA was 0.12 (0.05-0.15) and for SAPS-II 0.30 (0.08-0.48).

14 r operating characteristic curve (AUROC) for SAPS-II was 0.78 (95% CI 0.77-0.78) and 0.71 (0.70-0.72)

15 ted probability of in-hospital mortality for SAPS II was 0.72 (95% confidence interval, 0.57-0.87), f

16 ta support the notion that FyPP1/3, SAL (for SAPS DOMAIN-LIKE), and PP2AA proteins (RCN1 [for ROOTS C

17 This study used a human SAPS domain subunit FLAG-PP6R1 to identify endogenous in

18 howed differential distribution of the human SAPS-related mRNA in multiple human tissues, named as PP

19 Median simplified acute physiology score-II (SAPS-II) was 26.

20 ICU mortality calculators (e.g., APACHE II, SAPS II).

21 explanatory variables were categorised as in SAPS-II, and of 0.88 (0.87-0.89) when the same explanato

22 erin was associated with a -5.79 decrease in SAPS-PD scores compared with -2.73 for placebo (differen

23 24,508 patients were included, with median SAPS-II of 38 (IQR 27-51) and median SOFA of 5 (IQR 2-8)

24 Customization of SAPS II and MPM II0 to the Project IMPACT database resul

25 Customized versions of SAPS II and MPM II0 were obtained by fitting new logisti

26 ears old, simplified acute physiology score (SAPS) II 61 +/- 20) who underwent ECMO support for >48 h

27 ed on the Simplified Acute Physiology Score (SAPS) II and serum albumin level calculated before NPPV

28 ACHE III, Simplified Acute Physiology Score (SAPS) II, and Mortality Probability Models (MPM) II were

29 New Simplified Acute Physiology Score (SAPS) II, Morbidity Probability Model at admission (MPM0

30 BIAS is benchmarked against SEG, SAPS and CAST programs.

31 The results show SAPS domain subunits recruit substrates such as IkappaBe

32 nificance Analysis of Prognostic Signatures (SAPS) which integrates standard prognostic tests with a

33 d scale for assessment of positive symptoms (SAPS-PD) in all patients who received at least one dose

34 The SAPS domain of PP6R1 alone was sufficient for associatio

35 The SAPS proteins are more divergent in sequence than PP6.

36 edicts that conserved sequence motifs in the SAPS domain accounts for the specificity.

37 ables were the same as those included in the SAPS II score.

38 ed on the 17 variables as they appear in the SAPS-II score (SL1), and the second, on the original, un

39 This role is mediated by a protein of the SAPS-domain family involved in S-phase entry.

40 We propose that the SAPS and ankyrin repeat regulatory subunits determine th

41 We use SAPS to perform a large meta-analysis (the largest compl

42 ted with PP6, not with PP2A or PP4, and with SAPS domain subunits PP6R1 and PP6R3.

43 PP6 called Sit4 depends on association with SAPS domain subunits.

44 rtality based on Super Learner compared with SAPS-II, APACHE-II, and SOFA.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。